The global size is expected to reach USD 20.13 Billion in 2028 and register a revenue CAGR of 5.4% over the forecast period, according to the latest report by Emergen Research. Favorable government initiatives, increasing possibility of biological threats and attacks are factors driving global biodefense market revenue growth.
Get the Sample of the Report:
Biodefense is the use of medical measures to protect citizens against bioterrorism threats or possibility. Biodefense also includes production of stockpiles of vaccines and medication for people across the globe. Bioterrorism is an intentional release of harmful biological agents such as bacteria, viruses, and other germs to cause sickness/illness, and to harm humans, animals, or crops in a country or region.
To Know more: